Studies of Cannabinoid-Based Products in ClinicalTrials.gov: A Scoping Review (2025)

Registered studies on ClinicalTrials.gov using cannabinoid-based interventions were typically phase 2, randomized, and small (< 50 participants). The results of this review highlight the diverse nature of clinical studies across disease states and reinforce the need for larger, placebo-controlled st